0

Coronary Risk Factors Collection
 41-60 of 207 Articles
ACP Journal Club |  21 May 2013
Review: Replacing dietary saturated fatty acids with n-6 polyunsaturated fatty acids does not reduce mortality
Kathleen Fairfield, MD, DrPH
Ann Intern Med. 2013;158(10):JC6. doi:10.7326/0003-4819-158-10-201305210-02006
ACP Journal Club |  16 April 2013
Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD
Michael Tanner, MD, FACP
Ann Intern Med. 2013;158(8):JC4. doi:10.7326/0003-4819-158-8-201304160-02004
ACP Journal Club |  16 April 2013
Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
Saurav Chatterjee, MD; Sanjay Chatterjee, MD
Ann Intern Med. 2013;158(8):JC8. doi:10.7326/0003-4819-158-8-201304160-02008
ACP Journal Club |  19 March 2013
Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
Peter W. de Leeuw, MD
Ann Intern Med. 2013;158(6):JC7. doi:10.7326/0003-4819-158-6-201303190-02007
ACP Journal Club |  19 March 2013
PCI using drug-eluting stents had higher mortality than CABG in diabetes and multivessel CAD
Robert A. Harrington, MD
Ann Intern Med. 2013;158(6):JC8. doi:10.7326/0003-4819-158-6-201303190-02008
ACP Journal Club |  19 March 2013
Review: Continuous glucose monitoring reduces HbA1c more than self-monitoring in type 1 diabetes
A.C. Felix Burden, MD
Ann Intern Med. 2013;158(6):JC9. doi:10.7326/0003-4819-158-6-201303190-02009
ACP Journal Club |  15 January 2013
A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years
Jeffrey Mahon, MD, MSc
Ann Intern Med. 2013;158(2):JC4. doi:10.7326/0003-4819-158-2-201301150-02004
ACP Journal Club |  15 January 2013
Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes
Louise Moist, MD
Ann Intern Med. 2013;158(2):JC5. doi:10.7326/0003-4819-158-2-201301150-02005
ACP Journal Club |  18 December 2012
Review: Omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults
Donald A. Smith, MD, MPH, FACP, FNLA
Ann Intern Med. 2012;157(12):JC6-5. doi:10.7326/0003-4819-157-12-201212180-02005
ACP Journal Club |  18 December 2012
Review: Low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertension
James Brophy, MD, FRCP, PhD
Ann Intern Med. 2012;157(12):JC6-6. doi:10.7326/0003-4819-157-12-201212180-02006
ACP Journal Club |  18 December 2012
Review: Statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2012;157(12):JC6-8. doi:10.7326/0003-4819-157-12-201212180-02008
ACP Journal Club |  18 December 2012
Review: Eplerenone is not more effective for reducing mortality than other aldosterone antagonists
Ellis Lader, MD, FACC
Ann Intern Med. 2012;157(12):JC6-10. doi:10.7326/0003-4819-157-12-201212180-02010
ACP Journal Club |  18 December 2012
Novel risk markers improved Framingham Risk Score cardiovascular event prediction in intermediate-risk adults
Daniel I. Steinberg, MD
Ann Intern Med. 2012;157(12):JC6-13. doi:10.7326/0003-4819-157-12-201212180-02013
ACP Journal Club |  20 November 2012
Review: Statins decrease mortality and major CV events in adults with CKD not receiving dialysis
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-4. doi:10.7326/0003-4819-157-10-201211200-02004
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  16 October 2012
Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
Meera Jain, MD; Mark Rosenberg, MD
Ann Intern Med. 2012;157(8):JC4-2. doi:10.7326/0003-4819-157-8-201210160-02002
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  18 September 2012
Review: Varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults
Allan V. Prochazka, MD; Tanner J. Caverly, MD
Ann Intern Med. 2012;157(6):JC3-7. doi:10.7326/0003-4819-157-6-201209180-02007
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)